CALCA and diabetes mellitus: CGRP can influence the hypothalamo-pituitary axis, glucose and lipid metabolism [5, 144, 145], but up to now no hormonal dysregulation, significant weight changes or occurrence/aggravation of diabetes have been detected during anti-CGRP/rec mAb treatment.